Prevalence and outcomes of anemia in rheumatoid arthritis: A systematic review of the literature

American Journal of Medicine

Volumn 116, Issue 7 SUPPL. 1, 2004, Pages 50-57

  Wilson, Alisa ^a   Yu, Hsing Ting ^a   Goodnough, Lawrence Tim ^b   Nissenson, Allen R ^c  

^a Zynx Health   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTHROPATHY; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CORRELATION ANALYSIS; DEMOGRAPHY; EMBASE; HEALTH CARE COST; HUMAN; IRON DEFICIENCY ANEMIA; LITERATURE; MEDLINE; MUSCLE STRENGTH; PAIN ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SYMPTOMATOLOGY;

ACTIVITIES OF DAILY LIVING; ADULT; AGE DISTRIBUTION; ANEMIA; ARTHRITIS, RHEUMATOID; BLOOD TRANSFUSION; CHILD; COST OF ILLNESS; ERYTHROPOIETIN; FATIGUE; FEMALE; HAND STRENGTH; HUMANS; IRON; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PREVALENCE; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 1842472940     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.12.012     Document Type: Conference Paper

References (33)

1. Lee D.M., Weinblatt M. Rheumatoid arthritis. Lancet. 358:2001;903-911.
2. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 84:1997;223-243.
3. Lawrence R.C., Helmick C.G., Arnett F.C., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 41:1998;778-799.
4. Jenkins J.K., Hardy K.J., McMurray R.W. The pathogenesis of rheumatoid arthritis a guide to therapy. Am J Med Sci. 323:2002;171-180.
5. Schuna A.A. Autoimmune rheumatic diseases in women. J Am Pharm Assoc (Wash). 42:2002;612-623.
6. Fitzsimons E.J., Sturrock R.D. The chronic anaemia of rheumatoid arthritis iron banking or blocking? Lancet. 360:2002;1713-1714.
7. 12, and folic acid deficiency, and erythropoietin responsiveness. Ann Rheum Dis. 49:1990;93-98.
8. Ricerca B.M., Candido A., Alfano G., et al. The clinical value of the serum transferrin receptors in the anemia of rheumatoid arthritis. Supplemento di Haematologica. 79:1994;44-46.
9. Saikawa I., Hotokebuchi T., Arita C., et al. Autologous blood transfusion with recombinant erythropoietin treatment 22 arthroplasties for rheumatoid arthritis. Acta Orthop Scand. 65:1994;15-19.
10. Seth V., Kabra S.K., Semwal O.P., Jain Y. Clinico-immunological profile in juvenile rheumatoid arthritis - an Indian experience. Indian J Pediatr. 63:1996;293-300.
11. Takashina N., Kondo H., Kashiwazaki S. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis. J Rheumatol. 17:1990;885-887.
12. Baer A.N., Dessypris E.N., Krantz S.B. The pathogenesis of anemia in rheumatoid arthritis a clinical and laboratory analysis. Semin Arthritis Rheum. 19:1990;209-223.
13. Deep K.S., Singh H. Anaemia in rheumatoid arthritis. J Assoc Physicians India. 22:1974;743-749.
14. Griffiths H.J., Nicholson W.J., O'Gorman P. A haematological study of 500 elderly females. Gerontol Clin (Basel). 12:1970;18-32.
15. Hochberg M.C., Arnold C.M., Hogans B.B., Spivak J.L. Serum immunoreactive erythropoietin in rheumatoid arthritis impaired response to anemia. Arthritis Rheum. 31:1988;1318-1321.
16. Remacha A.F., Rodriguez-de la Serna A., Garcia-Die F., et al. Erythroid abnormalities in rheumatoid arthritis the role of erythropoietin. J Rheumatol. 19:1992;1687-1691.
17. Murphy E.A., Bell A.L., Wojtulewski J., et al. Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis. BMJ. 309:1994;1337-1338.
18. Tanaka N., Ito K., Ishii S., Yamazaki I. Autologous blood transfusion with recombinant erythropoietin treatment in anaemic patients with rheumatoid arthritis. Clin Rheumatol. 18:1999;293-298.
19. Peeters H.R., Jongen-Lavrencic M., Vreugdenhil G., Swaak A.J. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease a randomised placebo controlled double blind 52 weeks clinical trial. Ann Rheum Dis. 55:1996;739-744.
20. Pincus T., Olsen N.J., Russell I.J., et al. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med. 89:1990;161-168.
21. Nordström D., Lindroth Y., Marsal L., et al. Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis. Rheumatol Int. 17:1997;67-73.
22. Mercuriali F., Gualtieri G., Sinigaglia L., et al. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Transfusion. 34:1994;501-506.
23. Matsui H., Shiraishi N., Yasuda T., Nezuka T. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia. Clin Exp Rheumatol. 17:1999;69-74.
24. Kashiwazaki S, Mizushima Y, Nobunaga M, et al. Recombinant human erythropoietin therapy for anemia in rheumatoid arthritis. Jpn J Rheumatol. 1996;:333-344
25. Giordano N., Borghi N., Sancasciani S., et al. Efficacy and safety of an iron chelating agent, deferoxamine, in patients with rheumatoid arthritis and hyposideremic anemia. Curr Ther Res Clin Exp. 48:1990;959-968.
26. Kaltwasser J.P., Kessler U., Gottschalk R., et al. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol. 28:2001;2430-2436.
27. Fantini F., Gattinara M., Gerloni V., et al. Severe anemia associated with active systemic-onset juvenile rheumatoid arthritis successfully treated with recombinant human erythropoietin a pilot study. Arthritis Rheum. 35:1992;724-726.
28. Peeters H.R., Jongen-Lavrencic M., Bakker C.H., et al. Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease utility measures correlate strongly with disease activity measures. Rheumatol Int. 18:1999;201-206.
29. Avall A., Hyllner M., Bengtson J.P., et al. Postoperative inflammatory response after autologous and allogeneic blood transfusion. Anesthesiology. 87:1997;511-516.
30. Ritchie D.M., Boyle J.A., McInnes J.M., et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 37:1968;393-406.
31. Hunt S.M., McKenna S.P., McEwen J., et al. The Nottingham Health Profile subjective health status and medical consultations. Soc Sci Med [A]. 15:(Pt 1):1981;221-229.
32. Belza B. The impact of fatigue on exercise performance. Arthritis Care Res. 7:1994;176-180.
33. Goodnough L.T., Dubois R.W., Nissenson A.R. Anemia not just an innocent bystander? Arch Intern Med. 163:2003;1400-1404.